Key result
Cumulative non-HDL cholesterol exposure linked to ~91% higher ASCVD risk over six years.
Why the study?
The relationship between cumulative non-high-density lipoprotein cholesterol burden and atherosclerotic cardiovascular disease risk remains unclear.
Cohort (n=49,679)
No
Hazard Ratio: 1.91 (95% CI 1.59–2.31)
Absolute Event Rate: 4.4% vs 1.8%
p-value: p=<0.001
Cumulative non-HDL-C exposure may refine ASCVD risk stratification; extends observational duration data but leaves causal effects open for trials.
Background: The relationship between cumulative non-high-density lipoprotein cholesterol (non-HDL-C) burden and atherosclerotic cardiovascular disease (ASCVD) remains unclear. Objective: To prospectively examine the association between cumulative non-HDL-C burden and ASCVD risk in the Kailuan cohort of China. Methods: A total of 49,679 subjects who were free of ASCVD participated in three consecutive examinations in 2006, 2008 and 2010 were enrolled. Duration and concentration of cumulative exposure to non-HDL-C (cumNon-HDL-C) were respectively used to estimate the extent of cumulative non-HDL-C burden. The participants were divided into four groups according to durations of cumNon-HDL-C (0, 2, 4 and 6 years) and five groups according to the quintiles of cumNon-HDL-C concentration (<10.93, 10.93-12.68, 12.69-14.32, 14.33-16.72 and ≥16.73 mmol/L). Cox regression models were used to analyze the influence of cumulative non-HDL-C burden on ASCVD risk. Results: We identified 1,134 incident ASCVD cases during a mean of 4.89 years of follow-up. Multivariable adjusted analysis revealed that compared with no exposure, cumNon-HDL-C duration 2, 4 and 6 years increased ASCVD risk by 26% (HR: 1.26, 95% CI: 1.07-1.47), 56% (HR: 1.56, 95% CI: 1.31-1.86) and 91% (HR: 1.91, 95% CI: 1.59-2.31) respectively; The hazard ratios (HRs) for the fourth and fifth versus lowest quintile of cumNon-HDL-C concentration were 1.25 and 1.72 for ASCVD. Each standard deviation increment in cumNon-HDL-C concentration was associated with a 10% increased risk of ASCVD. Conclusion: Long-term and higher cumNon-HDL-C were all significantly associated with an increased risk of ASCVD independent of single non-HDL-C level.
No takes yet. Share an insight, caveat, or question.
Guan et al. (2023) conducted a cohort in Atherosclerotic cardiovascular disease (ASCVD) (n=49,679). Cumulative non-high-density lipoprotein cholesterol exposure vs. No exposure (0 years of exposure) was evaluated on Incident atherosclerotic cardiovascular disease (ASCVD) (HR 1.91, 95% CI 1.59-2.31, p=<0.001). Six years of cumulative non-high-density lipoprotein cholesterol exposure increased the risk of atherosclerotic cardiovascular disease by 91% compared with no exposure (HR 1.91).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: